Thailand Continuous Glucose Monitoring (CGM) Market - Strategic Insights and Forecasts (2026-2031)

The Thailand Continuous Glucose Monitoring (CGM) market is forecast to grow significantly, achieving a Compound Annual Growth Rate (CAGR) of 26.6% during the analysis period. This growth is expected to propel the market value from USD 0.8 million in 2026 to reach USD 2.6 million by 2031, reflecting increasing adoption and market expansion.

The report segments the Thailand Continuous Glucose Monitoring (CGM) market by application and end-user. This allows for a granular analysis of how different uses of CGM devices, such as for managing type 1 or type 2 diabetes, and various end-user environments, like hospitals or home care, contribute to the overall market dynamics.

The growth of the Thailand CGM market is primarily driven by the rising prevalence of type 1 and type 2 diabetes, with over 6 million Thai adults affected in 2021 and projections to reach 6.7 million by 2045. Additional drivers include increasing government initiatives to promote affordable diabetes care, continuous product launches by key market players, and advancements in technology innovation offering faster and smaller CGM solutions.

The report highlights that the high price of Continuous Glucose Monitoring (CGM) devices poses a significant challenge to market growth in Thailand. Furthermore, the lack of comprehensive reimbursement policies by medical insurance providers in the region currently obstructs wider accessibility and adoption among the diabetic population.

The report emphasizes that CGM devices are revolutionizing patient care by enhancing glucose management and significantly reducing episodes of hypoglycemia for individuals with diabetes. Strategic insights include the expansion of CGM use in hospitals for precise monitoring, its role in supporting convenient at-home care through wearable devices, and manufacturers' efforts to boost device affordability for wider access.

Government initiatives play a crucial role by promoting affordable diabetes care solutions and educating the public about diabetic healthcare, positively impacting CGM demand. Simultaneously, continuous technological innovations, such as the development of faster and smaller CGM models, are key in enhancing device utility and driving future market growth and patient adoption.